Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.71 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.56 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.56 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.56 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.56 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.56 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.56 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.56 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.56 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.56 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
| ▸ | DRD4 | P21917 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | HTR1B | P28222 | 2/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL95950 | 0.93 | KCNA3 (0.76) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL5173404 | 0.91 | KCNA3 (0.60) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL5175295 | 0.91 | KCNA3 (0.60) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL9327520 | 0.91 | KCNA3 (0.67) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL1004356 | 0.91 | KCNA3 (0.73) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL1006823 | 0.91 | KCNA3 (0.73) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL1006072 | 0.91 | KCNA3 (0.73) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL1006273 | 0.91 | KCNA3 (0.73) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL1004973 | 0.91 | KCNA3 (0.73) | KCNA3TAAR1ALDH1A1RECQLHDAC3 | |
| SCHEMBL97258 | 0.91 | KCNA3 (0.73) | KCNA3TAAR1ALDH1A1RECQLHDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6884868-B1 | Cyclic hexapeptides having antibiotic activity | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-04-26 | — | — | US | claimed |
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | claimed |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | claimed |
| WO-2004018461-A2 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
| WO-2004018428-A1 | ANTIBACTERIAL BENZOIC ACID DERIVATIVES | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-03-04 | — | — | WO | claimed |
| EP-0731095-B1 | 4-Alkylthio-pyrimidin-5-ylacetic acid derivatives | BAYER AG (DE) | 2002-07-03 | — | — | EP | claimed |
| EP-1173472-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-01-23 | — | — | EP | claimed |
| WO-2000064927-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-11-02 | — | — | WO | claimed |
| US-5776941-A | FUNGICIDES | SANDOZ LTD (CH) | 1998-07-07 | — | — | US | claimed |
| US-5324747-A | Treatment of inflammatory diseases | HOFFMANN-LA ROCHE INC. (US) | 1994-06-28 | — | — | US | claimed |
| EP-0579066-A2 | N-substituted anilines | F. HOFFMANN-LA ROCHE AG (CH) | 1994-01-19 | — | — | EP | claimed |
| EP-0274907-B1 | ANIONIC END-CAPPED OLIGOMERIC ESTERS AS SOIL RELEASE AGENTS IN DETERGENT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1992-08-12 | — | — | EP | claimed |
| EP-0274907-A1 | Anionic end-capped oligomeric esters as soil release agents in detergent compositions | THE PROCTER & GAMBLE COMPANY (US) | 1988-07-20 | — | — | EP | claimed |
| US-4721580-A | TEREPHTHALATE ESTERS WITHSODIUM SULFONATE END GROUPS | THE PROCTER & GAMBLE COMPANY (US) | 1988-01-26 | — | — | US | claimed |
| US-4331805-A | OPTICAL BRIGHTENERS | CIBA-GEIGY CORPORATION (US) | 1982-05-25 | — | — | US | claimed |
| US-4302586-A | FLUORESCENT WHITENERS | CIBA-GEIGY CORPORATION (US) | 1981-11-24 | — | — | US | claimed |
| US-4157443-A | OPTICAL BRIGHTENERS | CIBA-GEIGY CORPORATION (US) | 1979-06-05 | — | — | US | claimed |
| CN-109803956-B | Novel benzamide compound, process for producing the same, and acaricide | 日本欧爱特农业科技株式会社 | 2023-08-29 | — | — | CN | disclosed |
| US-4203757-A | Halophenoxyalkoxy phosphorous-containing sulfides | GAF CORPORATION (US) | 1980-05-20 | — | — | US | disclosed |
| US-4157443-A | OPTICAL BRIGHTENERS | CIBA-GEIGY CORPORATION (US) | 1979-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | KCNA3 3733/4885TAAR1 3551/4885ALDH1A1 123/4885 |
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | KCNA3 3491/4885TAAR1 3519/4885ALDH1A1 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.